Submit Deal

Submit Deal

Cover Image Mark Nathan Lampert

Mark Nathan Lampert

CEO and Founder at BVF PARTNERS

Investor

Deal Bio

Total Deals5

Valued Deals5

Total Value£471M

Avg. Deal Size£94M

Market Context

Expertise (5)

Key Relationships

Sort

Private EquityAcquisitionPrivateCross BorderVenture CapitalMinority

Alpha-9 Theranostics

target

Alpha-9 Theranostics

Quark Venture

bidder

Quark Venture

£60m

11 dealmakers

PrivateAcquisitionVenture CapitalDomesticMinorityPrivate Equity

Quanta Therapeutics

target

Quanta Therapeutics

Vida Ventures

bidder

Vida Ventures

£40m

11 dealmakers

Pharmaceuticals

DomesticAcquisitionMinorityPrivate EquityPublic

VERASTEM

target

VERASTEM

Bvf Partners

bidder

Bvf Partners

£48m

4 dealmakers

MinorityDomesticPrivate EquityAcquisitionPublic

Cidara Therapeutics

target

Cidara Therapeutics

Ra Capital Management

bidder

Ra Capital Management

£193m

8 dealmakers

AcquisitionCross BorderMinorityPrivateVenture Capital

Third Arc Bio

target

Third Arc Bio

Vida Ventures

bidder

Vida Ventures

£127m

14 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.